Granulocyte colony stimulating factor prevents kidney infarction and attenuates renovascular hypertension

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 143-152

  Nogueira, Breno V ^a   Palomino, Zaira ^c   Porto, Marcella L ^a,b   Balarini, Camille M ^a   Pereira, Thiago M C ^a   Baldo, Marcelo P ^a   Casarini, Dulce E ^c   Meyrelles, Silvana Santos ^a   Vasquez, Elisardo C ^a,b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Granulocyte colony stimulating factor (G CSF); Kidney infarct; Mice; Renin angiotensin system; Renovascular hypertension

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN II; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY INFARCTION; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

ANIMALIA; MUS;

EID: 84859827339     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337595     Document Type: Article

References (36)

1. Clark SC, Kamen R: The human hematopoietic colony-stimulating factors. Science 1987;236:1229-1237. (Pubitemid 17087886)
2. Gazitt Y: Immunologic profiles of effector cells and peripheral blood stem cells mobilized with different hematopoietic growth factors. Stem Cells 2000;18:390-398.
3. Takano H, Qin Y, Hasegawa H, Ueda K, Niitsuma Y, Ohtsuka M, Komuro I. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med 2006;84: 185-193. (Pubitemid 43291007)
4. Baldo MP, Rodrigues SL, Mill JG: Granulocyte colony-stimulating factor for ischemic heart failure: should we use it? Heart Fail Rev 2010;15:613-623.
5. Zaruba MM, Zhu W, Soonpaa MH, Reuter S, Franz WM, Field LJ: Granulocyte colony-stimulating factor treatment plus dipeptidylpeptidase-IV inhibition augments myocardial regeneration in mice expressing cyclin D2 in adult cardiomyocytes. Eur Heart J 2012;33:129-137.
6. Toth ZE, Leker RR, Shahar T, Pastorino S, Szalayova I, Asemenew B, Key S, Parmelee A, Mayer B, Nemeth K, Bratincsák A, Mezey E: The combination of granulocyte colony stimulatory factor and stem cell factor significantly increases the number of bone marrow derived endothelial cells in brains of mice following cerebral ischemia. Blood 2008;111:5544-5552.
7. Nishida M, Hamaoka K: How does GCSF act on the kidney during acute tubular injury? Nephron Exp Nephrol 2006;104:e123-e128. (Pubitemid 44885058)
8. Li Y, Wu J, Shou Z, He Q, Zhang P, Han F, Li H, Chen J: Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/ Akt signal pathway. Nephrology 2008;13:508-516.
9. Zubko R, Frishman W: Stem cell therapy for the kidney? Am J Ther 2009;16:247-56.
10. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T: Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 1997;29:1025-1030. (Pubitemid 27152476)
11. Arruda RMMP, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 2005;46:932-936.
12. Nogueira BV, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Arch Med Res 2007;38:816-821. (Pubitemid 47513267)
13. Jia N, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S: Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodeling. Clin Exp Pharmacol Physiol 2009;36:262-266.
14. Johns C, Gavras I, Handy DE, Salomao A, Gavras H: Models of experimental hypertension in mice. Hypertension 1996;28:1064-1069. (Pubitemid 26415825)
15. Hiyoshi H, Yayama K, Takano M, Okamoto H: Angiotensin type 2 receptor mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension. Hypertension 2005;45:967-973. (Pubitemid 40628945)
16. Iwasaki M, Adachi Y, Minamino K, Suzuki Y, Zhang Y, Okigaki M, Nakano K, Koike Y, Wang J, Mukaide H, Taketani S, Mori Y, Takahashi H, Iwasaka T, Ikehara S: Mobilization of bone marrow cells by GCSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 2005;16:658-666. (Pubitemid 41725102)
17. Stokman G, Leemans JC, Claessen N, Weening JJ, Florquin S: Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J Am Soc Nephrol 2005;16:1684-1692. (Pubitemid 41716474)
18. Akihama S, Sato K, Satoh S, Tsuchiya N, Kato T, Komatsuda A, Hirokawa M, Sawada K, Nanjo H, Habuchi T: Bone marrow-derived cells mobilized by granulocyte-colony stimulating factor facilitate vascular regeneration in mouse kidney after ischemia/reperfusion injury. Tohoku J Exp Med 2007;213:341-349.
19. Rakušan D, Bürgelová M, Vanìèková I, Vaòourková Z, Husková Z, Skaroupková P, Mrázová I, Opoèenský M, Kramer HJ, Netuka I, Malý J, Alenina N, Bader M, Santos RA, Cervenka L: Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II. Kidney Blood Press Res 2010;33:476-488.
20. Santos RA, Ferreira AJ: Angiotensin-(1-7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens 2007;16:122-128.
21. Richter CM, Godes M, Wagner C, Maser-Gluth C, Herzfeld S, Dorn M, Priem F, Slowinski T, Bauer C, Schneider W, Neumayer HH, Kurtz A, Hocher B: Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats. J Hypertens 2004;22:191-198. (Pubitemid 38293547)
22. Stokman G, Leemans JC, Stroo I, Hoedemaeker I, Claessen N, Teske GJ, Weening JJ, Florquin S: Enhanced mobilization of bone marrow cells does not ameliorate renal fibrosis. Nephrol Dial Transplant 2008;23:483-491. (Pubitemid 351767621)
23. Peng JF, Gurantz D, Tran V, Cowling RT, Greenberg BH: Tumor necrosis factor-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. Circ Res 2002;91:1119-1126. (Pubitemid 36076360)
24. Li Y, Takemura G, Okada H, Miyata S, Esaki M, Maruyama R, Kanamori H, Li L, Ogino A, Misao Y, Khai NC, Mikami A, Minatoguchi S, Fujiwara T, Fujiwara H: Treatment with granulocyte colonystimulating factor ameliorates chronic heart failure. Lab Invest 2006;86:32-44. (Pubitemid 43250966)
25. Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath KA, Grande JP: Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 2009;297:F1055-F1068.
26. Theilig F, Debiec H, Nafz B, Ronco P, Nüsing R, Seyberth HW, Pavenstädt H, Bouby N, Bachmann S: Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat). Am J Physiol Renal Physiol 2006;291:F987-F994. (Pubitemid 44772032)
27. Santos CM, Johnson RF, Beltz TG, Thunhorst RL, Johnson AK: Water intake during the development of renal hypertension (2K-1C) in mice. Physiol Behav 2005;85:512-516. (Pubitemid 41020766)
28. Lazartigues E, Sinnayah P, Augoyard G, Gharib C, Johnson AK, Davisson RL: Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors. Am J Physiol Regul Integr Comp Physiol 2008;295:R1539-1545.
29. Tögel F, Isaac J, Westenfelder C: Hematopoietic stem cell mobilizationassociated granulocytosis severely worsens acute renal failure. J Am Soc Nephrol 2004;15:1261-1267. (Pubitemid 38526007)
30. Furze RC, Rankin SM: Neutrophil mobilization and clearance in the bone marrow Immunology 2008; 125, 281-288.
31. Furze RC, Rankin SM: The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. FASEB J 2008;22:3111-3119.
32. Hübel K, Engert A: Clinical applications of granulocyte colony-stimulating factor: an update and summary. Ann Hematol 2003;82:207-213. (Pubitemid 36701010)
33. Stroncek D, Shawker T, Follmann D, Leitman SF: G-CSF-induced spleen size changes in peripheral blood progenitor cell donors. Transfusion 2003;43:609-613. (Pubitemid 36506357)
34. To LB, Haylock DN, Simmons PJ, Juttner CA: The biology and clinical uses of blood stem cells. Blood 1997;89:2233-2258. (Pubitemid 27143269)
35. Rodgers KE, Xiong S, Steer R, Dizerega GS: Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 2000;18:287-294. (Pubitemid 30602276)
36. Haznedaroglu IC, Öztürk MA: Towards the understanding of the local hematopoietic bone marrow reninangiotensin system. Int J Biochem Cell Biol 2003;35:867-880. (Pubitemid 36379328)